Importantly, therapeutic strategies targeting single inflammatory mediators, such as anti-TNF-α antibodies, have failed in clinical sepsis [34], highlighting the potential advantage of agents like MLT that simultaneously modulate multiple signaling pathways. Here, TNF is linked to Sepsis.